in K$
(1)
Line impacted
in the
consolidated
P&L
Product sales to Sanofi
Royalties paid by Sanofi
R&D expense incurred by the Company funded by Sanofi
(1) Positive amount = income; Negative amount = expense
OTHER GAINS & LOSSES RELATING TO TRANSACTIONS WITH SANOFI
(Amounts >5M$) - to be detailed
Example: Gain or loss on non-current asset disposals to Sanofi.
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH
"[***]". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE
SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION
REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE
ACT OF 1934.
C-8